Similar articles

• Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.

  Mendlewicz J, Pinder RM, Stulemeijer SM, Van Dorth R. Mendlewicz J, et al. J Affect Disord. 1982 Sep;4(3):219-26. doi: 10.1016/0165-0327(82)90006-4. J Affect Disord. 1982. PMID: 6182175 Clinical Trial.
• A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.

  Dimitriou EC, Logothetis JA, Paschalidou M. Dimitriou EC, et al. Adv Biochem Psychopharmacol. 1982;32:213-22. Adv Biochem Psychopharmacol. 1982. PMID: 7046365 Clinical Trial.
• CSF monoamine metabolites, depression, and suicide.

  Asberg M, Bertilsson L, Mårtensson B. Asberg M, et al. Adv Biochem Psychopharmacol. 1984;39:87-97. Adv Biochem Psychopharmacol. 1984. PMID: 6205566 Review. No abstract available.
• Treating the depressed elderly patient: the comparative behavioral pharmacology of mianserin and amitriptyline.

  Branconnier RJ, Cole JO, Ghazvinian S, Rosenthal S. Branconnier RJ, et al. Adv Biochem Psychopharmacol. 1982;32:195-212. Adv Biochem Psychopharmacol. 1982. PMID: 7046364 Clinical Trial.
• Genetic studies of CSF monoamine metabolites.

  Sedvall G, Iselius L, Nybäck H, Oreland L, Oxenstierna G, Ross SB, Wiesel FA. Sedvall G, et al. Adv Biochem Psychopharmacol. 1984;39:79-85. Adv Biochem Psychopharmacol. 1984. PMID: 6205565 Review. No abstract available.